Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study.

导出 LinkOut

翻译打印收藏纠错

作者： György,Rokszin ^[1] ; Zoltán,Kiss ^[2] ; Gábor,Sütő ^[2] ; Péter,Kempler ^[3] ; György,Jermendy ^[4] ; Ibolya,Fábián ^[5] ; Zoltán,Szekanecz ^[6] ; Gyula,Poór ^[7] ; István,Wittmann ^[2] ; Gergő Attila,Molnár ^[2]

作者单位： RxTarget Ltd, Szolnok, Hungary. ^[1] Second Department of Medicine and Nephrology-Diabetes Centre, University of Pécs Medical School, Pécs, Hungary. ^[2] Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary. ^[3] Bajcsy-Zsilinszky Hospital, Budapest, Hungary. ^[4] RxTarget Ltd, Szolnok, Hungary.;Faculty of Mathematics, University of Veterinary Medicine, Budapest, Hungary. ^[5] Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. ^[6] National Institute of Rheumatology and Physiotherapy, Budapest, Hungary. ^[7]

关键词 antidiabetic treatment cancer diabetes mellitus type 2 dipeptidyl peptidase (DPP)-4 inhibitors sodium-glucose co-transporter 2 (SGLT 2) inhibitors

DOI 10.3389/fonc.2021.725465

PMID 34778040

发布时间 2024-08-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2021年11卷

725465页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除